FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078101418> ?p ?o ?g. }

• W2078101418 endingPage "587" @default.
• W2078101418 startingPage "579" @default.
• W2078101418 abstract "Objective: To investigate the possible mechanisms of the antiatherosclerotic effects of the angiotensin-converting enzyme (ACE) inhibitor, fosinopril, in apolipoprotein (apo) E deficient mice. Methods: Apo E deficient (E0) mice at the age of 8 weeks received either placebo or a high dose (25 mg/kg/d) of fosinopril supplemented in their drinking water. Results: After 12 weeks of treatment, fosinopril reduced the aortic lesion size by 70%, compared with the placebo group. At this dosage, fosinopril significantly reduced blood pressure from 93±2 mmHg before treatment to 70±2 mmHg at the end of the treatment period (P<0.005). Fosinopril also increased the resistance of the mice plasma low density lipoprotein (LDL) to CuSO4-induced oxidation, as shown by a 90% reduction in the LDL content of malondialdehyde (MDA) and also by a prolongation of the lag time required for the initiation of LDL oxidation (from 100 min in the placebo-treated mice to more than 240 min in the fosinopril-treated mice; P<0.001). In addition, fosinopril inhibited CuSO4-induced oxidation of LDL that was obtained from the aortas of the treated mice, as shown by an 18% and 37% reduction in the LDL content of lipid peroxides and hydroperoxy-cholesterol linoleate, respectively, compared with the placebo-treated mice (P<0.01). A low dosage of fosinopril (5 mg/kg/d) that was still adequate to reduce their plasma ACE activity and LDL propensity to lipid peroxidation was insufficient to lower their blood pressure. This dosage also reduced the aortic lesion size in the apo E deficient mice by 40% (P<0.01). Conclusions: The antiatherogenic effects of fosinopril in apo E deficient mice are due not only to blood pressure reduction but also to the direct inhibition of angiotensin II-dependent effects, which are probably also associated with the inhibition of LDL oxidation." @default.
• W2078101418 created "2016-06-24" @default.
• W2078101418 creator A5060842824 @default.
• W2078101418 date "1999-12-01" @default.
• W2078101418 modified "2023-09-25" @default.
• W2078101418 title "The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice" @default.
• W2078101418 cites W1164770037 @default.
• W2078101418 cites W1590457525 @default.
• W2078101418 cites W1597723737 @default.
• W2078101418 cites W1775749144 @default.
• W2078101418 cites W1857052429 @default.
• W2078101418 cites W1859624620 @default.
• W2078101418 cites W1964206499 @default.
• W2078101418 cites W1964814612 @default.
• W2078101418 cites W1980000060 @default.
• W2078101418 cites W1992167081 @default.
• W2078101418 cites W1994918206 @default.
• W2078101418 cites W1995409032 @default.
• W2078101418 cites W2004388218 @default.
• W2078101418 cites W2009359363 @default.
• W2078101418 cites W2013286419 @default.
• W2078101418 cites W2014575233 @default.
• W2078101418 cites W2015885846 @default.
• W2078101418 cites W2019729784 @default.
• W2078101418 cites W2022421975 @default.
• W2078101418 cites W2022456632 @default.
• W2078101418 cites W2025862646 @default.
• W2078101418 cites W203342931 @default.
• W2078101418 cites W2033859371 @default.
• W2078101418 cites W2034714871 @default.
• W2078101418 cites W2035252462 @default.
• W2078101418 cites W2040923416 @default.
• W2078101418 cites W2048890665 @default.
• W2078101418 cites W2057960696 @default.
• W2078101418 cites W2062282696 @default.
• W2078101418 cites W2069445171 @default.
• W2078101418 cites W2071782926 @default.
• W2078101418 cites W2075607851 @default.
• W2078101418 cites W2076907458 @default.
• W2078101418 cites W2080767801 @default.
• W2078101418 cites W2089397502 @default.
• W2078101418 cites W2095840354 @default.
• W2078101418 cites W2097933389 @default.
• W2078101418 cites W2098646953 @default.
• W2078101418 cites W2109738937 @default.
• W2078101418 cites W2111313621 @default.
• W2078101418 cites W2118600056 @default.
• W2078101418 cites W2127203967 @default.
• W2078101418 cites W2128139183 @default.
• W2078101418 cites W2129281825 @default.
• W2078101418 cites W2129902852 @default.
• W2078101418 cites W2139480984 @default.
• W2078101418 cites W2141659719 @default.
• W2078101418 cites W2145879452 @default.
• W2078101418 cites W2149982036 @default.
• W2078101418 cites W2168800815 @default.
• W2078101418 cites W2184312156 @default.
• W2078101418 cites W2187715873 @default.
• W2078101418 cites W2312388685 @default.
• W2078101418 cites W2313265082 @default.
• W2078101418 cites W2341645956 @default.
• W2078101418 cites W2410922985 @default.
• W2078101418 cites W2414668996 @default.
• W2078101418 cites W3022864527 @default.
• W2078101418 cites W103429211 @default.
• W2078101418 doi "https://doi.org/10.1016/s0008-6363(99)00239-4" @default.
• W2078101418 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10690290" @default.
• W2078101418 hasPublicationYear "1999" @default.
• W2078101418 type Work @default.
• W2078101418 sameAs 2078101418 @default.
• W2078101418 citedByCount "140" @default.
• W2078101418 countsByYear W20781014182012 @default.
• W2078101418 countsByYear W20781014182013 @default.
• W2078101418 countsByYear W20781014182014 @default.
• W2078101418 countsByYear W20781014182015 @default.
• W2078101418 countsByYear W20781014182016 @default.
• W2078101418 countsByYear W20781014182018 @default.
• W2078101418 countsByYear W20781014182019 @default.
• W2078101418 countsByYear W20781014182020 @default.
• W2078101418 countsByYear W20781014182021 @default.
• W2078101418 countsByYear W20781014182023 @default.
• W2078101418 crossrefType "journal-article" @default.
• W2078101418 hasAuthorship W2078101418A5060842824 @default.
• W2078101418 hasBestOaLocation W20781014181 @default.
• W2078101418 hasConcept C126322002 @default.
• W2078101418 hasConcept C134018914 @default.
• W2078101418 hasConcept C185592680 @default.
• W2078101418 hasConcept C27016395 @default.
• W2078101418 hasConcept C2776151105 @default.
• W2078101418 hasConcept C2778163477 @default.
• W2078101418 hasConcept C2778401633 @default.
• W2078101418 hasConcept C2779611605 @default.
• W2078101418 hasConcept C2780288358 @default.
• W2078101418 hasConcept C2780436477 @default.
• W2078101418 hasConcept C2908929049 @default.
• W2078101418 hasConcept C62746215 @default.
• W2078101418 hasConcept C71924100 @default.
• W2078101418 hasConcept C84393581 @default.

• next